ABBV/ENTA's PDUFA date for the 3-DAA regimen is on or around 12/21/14. ABBV issued the PR for the NDA submission before the open on 4/22/14, suggesting that the submission may have occurred on the 21st.
The FDA does not publicly disclose PDUFA dates.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.